系統名(カルタヘナ情報) | マウス NOG-hGM-CSF/hIL-3 Tg |
---|---|
系統名(略称) | NOG-EXLマウス |
SRaプロモーター下流にヒトIL-3またはGM-CSF遺伝子を配置したベクターをC57BL/6J-scidマウス胚へマイクロインジェクションし、得られたトランスジェニックマウスをNOGマウスへバッククロスして作製しました。
Ryoji Ito et al., J Immunol 2013
NOGマウスの特徴に以下の特徴が追加されています。
(注1)通常、がん細胞株(またはPDX腫瘍)はお客様に準備していただいておりますが、購入可能な細胞の場合は弊社で購入することも可能です。
NOG-EXLマウスの開発経緯、および、HSCを移入したNOG-EXLマウス(ヒト化マウス)の特徴、主な研究用途をご紹介します。
Kidney Immune Cell Characterization of Humanized Mouse Models.(NOG mouse, NOG-EXL mouse, PBMC)
Kidney360. 2024 Jan 1;5(1):96-109. doi: 10.34067/KID.0000000000000300. Epub 2023 Dec 1.PMID: 38037230
Noel S, Kurzhagen JT, Lee SA, Sadasivam M, Hamad ARA, Pierorazio PM, Rabb H.Improvement of multilineage hematopoiesis in hematopoietic stem cell-transferred c-kit mutant NOG-EXL humanized mice (CD34+ cells; Hematopoiesis; Hematopoietic stem cells; Humanized mice; NOG mouse, NOG-EXL mouse)
Stem Cell Res Ther. 2024 Jun 21;15(1):182. doi: 10.1186/s13287-024-03799-w.
Ito R, Ohno Y, Mu Y, Ka Y, Ito S, Emi-Sugie M, Mochizuki M, Kawai K, Goto M, Ogura T, Takahashi R, Niwa A, Nakahata T, Ito M.Diagnostic challenge in veterinary pathology: Otitis in a humanized NOG-EXL mouse (veterinary pathology, Otitis, NOG-EXL mouse)
Vet Pathol. 2024 Sep 21:3009858241279141. doi: 10.1177/03009858241279141.
Willis E, Verrelle J, Secreto A, Cole SD, McClung G, Weinfurtner KM, Gade TPF, Radaelli E.Humanization with CD34-positive hematopoietic stem cells in NOG-EXL mice results in improved long-term survival and less severe myeloid cell hyperactivation phenotype relative to NSG-SGM3 mice (NOG-EXL mouse; NSG-SGM3 mouse; hemophagocytic lymphohistiocytosis; human hematopoietic stem cells; humanization; macrophage activation syndrome; mast cell hyperplasia; mouse.)
Vet Pathol. 2024 Jul;61(4):664-674. doi: 10.1177/03009858231222216. Epub 2024 Jan 10.
Willis E, Verrelle J, Banerjee E, Assenmacher CA, Tarrant JC, Skuli N, Jacobson ML, O'Rouke DM, Binder ZA, Radaelli E.TNFSF11/TNFRSF11A Axis Amplifies HDM-Induced Airway Remodeling by Strengthening TGFβ1/STAT3 Action(HDM; TNFRSF11A; TNFSF11; airway remodeling; HSC NOG-EXL mouse)
Allergy Asthma Immunol Res. 2024 Jul;16(4):399-421. doi: 10.4168/aair.2024.16.4.399.
Zhang D, Zhang J, Qi Q, Pan Y, Zeng R, Xu C, Liu X, Xu J, Gao M, Gao T, Zhang J, Shi S, Dong L.Plonmarlimab, a novel anti-GM-CSF blocking antibody, ameliorates disease progression in the pre-clinical model of macrophage activation syndrome(autoinflammatory disease; immunotherapy; macrophage; NOG-EXL)
Immunology. 2024 Nov;173(3):552-561. doi: 10.1111/imm.13842. Epub 2024 Aug 2.
Ding J, Xu K, Niu Y, Qin Y, Shen H, Wang Y, Guo W, Liu X, Wang Z, Zhu AX.Human GM-CSF/IL-3 enhance tumor immune infiltration in humanized HCC patient-derived xenografts (HCC PDX; HSC; NOG; NOG-EXL (huGM-CSF/huIL-3 NOG) mice)
bioRxiv [Preprint]. 2024 Oct 31:2023.10.05.561117. doi: 10.1101/2023.10.05.561117.
Weinfurtner K, Tischfield D, McClung G, Crainic J, Gordan J, Jiao J, Furth EE, Li W, Tuzneen Supan E, Nadolski GJ, Hunt SJ, Kaplan DE, Gade TPF.A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD Derived Mouse Strains.(CD34; NCG; NOG-EXL; NSG; NSG SGM3; humanization; humanized mouse model; lymphoid; myeloid; xenograft.)
Microorganisms. 2023 Jun 10;11(6):1548. doi: 10.3390/microorganisms11061548.PMID: 37375051
Gutierrez-Barbosa H, Medina-Moreno S, Perdomo-Celis F, Davis H, Coronel-Ruiz C, Zapata JC, Chua JV.Spontaneous early-onset neurodegeneration in the brainstem and spinal cord of NSG, NOG, and NXG mice.(CD34; NOG; NOG-EXL; NSG; NXG; gliosis; neurodegeneration; spontaneous lesion; vacuolation)
Vet Pathol. 2023 May;60(3):374 383. doi: 10.1177/03009858231151403. Epub 2023 Feb 2.
Finesso G, Willis E, Tarrant JC, Lanza M, Sprengers J, Verrelle J, Banerjee E, Hermans E, Assenmacher CA, Radaelli E.Clinically relevant humanized mouse models of metastatic prostate cancer to evaluate cancer therapies.(humanized mice, NOG, NOG-EXL, Hot Model, Cold Model, metastatic prostate cancer, cancer therapy)
bioRxiv . 2023 Oct 17:2023.10.13.562280. doi: 10.1101/2023.10.13.562280. Preprint.
Kostlan RJ, Phoenix JT, Budreika A, Ferrari MG, Khurana N, Cho JE, Juckette K, McCollum BL, Moskal R, Mannan R, Qiao Y, Griend DJV, Chinnaiyan AM, Kregel S.PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway.(CCL20-modulated PMN-MDSCs, polymorphonuclear myeloid-derived suppressor cells, huNOG-EXL)
Signal Transduct Target Ther 2023 Mar 1;8(1):97. doi: 10.1038/s41392 023 01337 3.
Rui Zhang,Mengxue Dong, Juchuanli Tu, Fengkai Li, Qiaodan Deng, Jiahui Xu, Xueyan He, Jiajun Ding, Jie Xia, Dandan Sheng, Zhaoxia Chang, Wei Ma, Haonan Dong, Yi Zhang, Lixing Zhang, Lu Zhang, Suling LiuCo-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML. (AML, NOG-EXL)
In Vivo. 2022 Jul-Aug;36(4):1615-1627. doi: 10.21873/invivo.12872.
Daniel H Albert, Neal C Goodwin, Angela M Davies, Jenny Rowe, Gerold Feuer, Michael Boyiadzis, Kathleen A Dorritie, Maria Mancini, Regina Gandour-Edwards, Brian A Jonas, Gautam Borthakur, Ibrahim Aldoss, David A Rizzieri, Olatoyosi Odenike, Thomas Prebet, Sanjana Singh, Relja Popovic, Y U Shen, Keith F McDaniel, Warren M Kati, Dimple A Modi, Monica Motwani, Johannes E Wolff, David J FrostEliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors.(CML-LSCs, NOG-EXL)
Nature Communications volume 13, Article number: 271 (2022)
Yosuke Tanaka, Reina Takeda, Tsuyoshi Fukushima, Keiko Mikami, Shun Tsuchiya, Moe Tamura, Keito Adachi, Terumasa Umemoto, Shuhei Asada, Naoki Watanabe, Soji Morishita, Misa Imai, Masayoshi Nagata, Marito Araki, Hitoshi Takizawa, Tomofusa Fukuyama, Chrystelle Lamagna, Esteban S. Masuda, Ryoji Ito, Susumu Goyama, Norio Komatsu, Tomoiku Takaku & Toshio KitamuraTransplantation of insulin-producing cells derived from human mesenchymal stromal/stem cells into diabetic humanized mice. (hAT-MSCs, NOG-EXL)
Stem Cell Res Ther. 2022 Jul 26;13(1):350. doi: 10.1186/s13287-022-03048-y.
Ghoneim MA, Gabr MM, Refaie AF, El-Halawani SM, Al-Issawi MM, Elbassiouny BL, Kader MAAE, Ismail AM, Zidan MF, Karras MS, Magar RW, Khater SM, Ashamallah SA, Zakaria MM, Kloc M.Bovine β-lactoglobulin-induced passive systemic anaphylaxis model using humanized NOG hIL-3/hGM-CSF transgenic mice. (passive systemic anaphylaxis model, NOG-EXL )
Int Immunol. 2021 Mar 1;33(3):183-189. doi: 10.1093/intimm/dxaa067.
Ito R, Katano I, Otsuka I, Takahashi T, Suemizu H, Ito M, Simons PJ.The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models. (pDC, humanized mice, NOG-EXL)
Front Immunol. 2020 Sep 8;11:2082. doi:10.3389/fimmu.2020.02082. eCollection 2020.
Maser IP, Hoves S, Bayer C, Heidkamp G, Nimmerjahn F, Eckmann J, Ries CH.Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents. (humanized mice, NOG-EXL, Immune oncology, PDX)
Curr Protoc Pharmacol. 2020 Jun;89(1):e77. doi: 10.1002/cpph.77.
Ghoneim MA, Gabr MM, Refaie AF, El-Halawani SM, Al-Issawi MM, Elbassiouny BL, Kader MAAE, Ismail AM, Zidan MF, Karras MS, Magar RW, Khater SM, Ashamallah SA, Zakaria MM, Kloc M.HIV Replication in Humanized IL-3/GM-CSF-Transgenic NOG Mice. (humanized mice, NOG-EXL, HIV)
Pathogens. 2019 Mar 12;8(1):33. doi: 10.3390/pathogens8010033.
Perdomo-Celis F, Medina-Moreno S, Davis H, Bryant J, Zapata JC.BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains. (NOG, NOG-EXL)
Toxicol Sci. 2019 May 1;169(1):194-208. doi: 10.1093/toxsci/kfz045.
Weaver JL, Zadrozny LM, Gabrielson K, Semple KM, Shea KI, Howard KE.Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice. (human allergy, NOG-EXL)
J Immunol. 2013 Sep 15;191(6):2890-9. doi: 10.4049/jimmunol.1203543. Epub 2013 Aug 16.
Ryoji Ito, Takeshi Takahashi, Ikumi Katano, Kenji Kawai, Tsutomu Kamisako, Tomoyuki Ogura, Miyuki Ida-Tanaka, Hiroshi Suemizu, Satoshi Nunomura, Chisei Ra, Akio Mori, Sadakazu Aiso, Mamoru Ito